We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

125 hedge funds and large institutions have $892M invested in Amicus Therapeutics in 2015 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 22

50% more funds holding in top 10

Funds holding in top 10: 6 → 9 (+3)

35% more capital invested

Capital invested by funds: $662M → $892M (+$231M)

24% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 33

15% more funds holding

Funds holding: 109 → 125 (+16)

4% less call options, than puts

Call options by funds: $12.4M | Put options by funds: $12.8M

Holders
125
Holders Change
+16
Holders Change %
+14.68%
% of All Funds
3.33%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.24%
New
38
Increased
41
Reduced
33
Closed
22
Calls
$12.4M
Puts
$12.8M
Net Calls
-$475K
Net Calls Change
-$899K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$13.8M
2
ACA
Avoro Capital Advisors
New York
+$12.2M
3
Millennium Management
Millennium Management
New York
+$6.44M
4
EA
Emerald Advisers
Pennsylvania
+$6.19M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$6.08M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$47M
2
RG
Redmile Group
California
-$9.19M
3
BIM
Bogle Investment Management
Massachusetts
-$5.82M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.29M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
QI
51
QS Investors
New York
$2.15M – – –
GKIM
52
GW&K Investment Management
Massachusetts
$2.13M +$1.73M +196,235 New
RFC
53
Russell Frank Company
Washington
$2.06M -$893K -101,340 -35%
Ameriprise
54
Ameriprise
Minnesota
$2.05M -$418K -47,474 -20%
ARTA
55
A.R.T. Advisors
New York
$1.93M -$1.05M -119,612 -40%
Point72 Asset Management
56
Point72 Asset Management
Connecticut
$1.89M +$1.53M +173,900 New
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$1.85M – – –
Northern Trust
58
Northern Trust
Illinois
$1.8M +$160K +18,149 +12%
BCM
59
BlueCrest Capital Management
Jersey
$1.78M +$1.44M +163,920 New
ACM
60
Atika Capital Management
New York
$1.77M -$326K -37,000 -19%
BA
61
BlackRock Advisors
Delaware
$1.77M -$538K -61,010 -27%
MCM
62
Moore Capital Management
New York
$1.53M -$744K -84,359 -37%
SGAM
63
Smith Group Asset Management
Texas
$1.48M -$1.03M -117,330 -46%
PP
64
PDT Partners
New York
$1.47M +$312K +35,402 +36%
UOC
65
UBS O'Connor
Illinois
$1.36M -$281K -31,884 -20%
GMIM
66
General Motors Investment Management
New York
$1.14M +$927K +105,203 New
TC
67
TFS Capital
Pennsylvania
$1.14M -$3.41M -386,917 -79%
HLA
68
Hamilton Lane Advisors
Pennsylvania
$1.07M +$865K +98,119 New
AQR Capital Management
69
AQR Capital Management
Connecticut
$981K +$157K +17,800 +25%
Swiss National Bank
70
Swiss National Bank
Switzerland
$864K +$141K +16,000 +25%
ProShare Advisors
71
ProShare Advisors
Maryland
$838K +$135K +15,280 +25%
SEP
72
Sound Energy Partners
Connecticut
$723K -$220K -25,000 -27%
PAM
73
Panagora Asset Management
Massachusetts
$721K +$584K +66,282 New
TI
74
Trexquant Investment
Connecticut
$707K -$59.1K -6,700 -9%
Neuberger Berman Group
75
Neuberger Berman Group
New York
$653K -$264K -30,000 -33%
1 2
3
4 5

FOLD Hedge Fund Activity: Q1 2015 in Review

125 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q1 2015, worth a combined $892M — up 35% from $662M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new FOLD positions and 22 closed out — a net gain of 16 holders — while 41 added to existing stakes and 33 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $13.8M. The largest seller was NEA Management Company, exiting entirely with an estimated $47M sold.

  • 125 institutional investors held Amicus Therapeutics (FOLD) as of Q1 2015, up from 109 in Q4 2014.
  • Funds reported $892M of Amicus Therapeutics stock for Q1 2015, up 35% quarter-over-quarter.
  • 38 funds opened new Amicus Therapeutics positions in Q1 2015 and 22 closed out, a net change of +16 holders.
  • The largest Amicus Therapeutics buyer in Q1 2015 was Citadel Advisors, an estimated $13.8M added.
  • The largest Amicus Therapeutics seller in Q1 2015 was NEA Management Company, an estimated $47M sold.

Based on aggregated 13F filings for Q1 2015.